Novel Strategies for the Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome

5,573
Total downloads
24k
Total views and downloads

Articles

ORIGINAL RESEARCH

Accepted on 25 Aug 2025

Associations between triglyceride glucose-body mass index and cardiovascular, renal, hepatic and bone biomarkers in patients with type 2 diabetes: A single-center, cross-sectional study

Nan Xu
Kun-Yi Wu
Ting La
Ruo Zhang
Bo Cao

doi 10.3389/fendo.2025.1566818

ORIGINAL RESEARCH

Accepted on 25 Aug 2025

The impact of short-term comprehensive treatment on cardiovascular-kidney-metabolic syndrome and its components in patients with type 2 diabetes

Li Gong
Ruirui Yang
Huanhuan Cui
Jing Zhao
Jing Liu
Xiaoshuang Lv
Jing Ding

doi 10.3389/fendo.2025.1659340

ORIGINAL RESEARCH

Published on 22 Aug 2025

Comparison of triglyceride-glucose index and triglyceride-glucose related indexes in predicting cardiovascular disease incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study

Qingsong Mao
Nianzhou Liu
Tian Xiong
Xinyi Wang
Xinling Tian
Yuzhe Kong

doi 10.3389/fendo.2025.1562135

353 views

ORIGINAL RESEARCH

Accepted on 18 Aug 2025

Osteoarthritis as a Clinical Marker of Cardiovascular-Kidney-Metabolic Multimorbidity: A Population-Based Cohort Study in China

Yue Zou
Yanyan Zhang
Xiujiang Sun
Wenbo Zhao
Guodong Zhang

doi 10.3389/fendo.2025.1660319

204 views

ORIGINAL RESEARCH

Accepted on 18 Aug 2025

Association Between Onset Age and Mortality Gradients in Advanced Cardio-Kidney-Metabolic Syndrome

Jinjin Dai
Chuanchang Wu
Shihua Liu
Shuohua Chen
Xiaodan Hong
Pengyue Zhang
Liufu Cui
Shouling Wu
Zhenhua Zhang

doi 10.3389/fendo.2025.1648083

ORIGINAL RESEARCH

Accepted on 05 Aug 2025

Alcohol Consumption, High-Sensitivity C-Reactive Protein, and Estimated Glomerular Filtration Rate: Tripartite Predictors of 10-Year Cardiovascular Risk Progression in Patients with Type 2 Diabetes Mellitus After COVID-19

Yizhe Wang
Yu Duan
Yongcheng Zhang
Na Li
Ying Hu
Yuhang Ma
Yanfang Hou
Liping Gu

doi 10.3389/fendo.2025.1609144

219 views

ORIGINAL RESEARCH

Accepted on 05 Aug 2025

Risk Factors for Advance Stage Cardiovascular-Renal-Metabolic Syndrome in Patients with Early-Onset Type 2 Diabetes Mellitus

Yujuan Zhang
Chang Li
Qingyang Leng
Jinghao Pan
Hongli Zhang
Xiaohua Li

doi 10.3389/fendo.2025.1659544

274 views

ORIGINAL RESEARCH

Published on 10 Jul 2025

Cardiovascular-kidney-metabolic comorbidities in colorectal cancer survivors: a nationwide cohort study on the role of metabolic syndrome

Xin Liu
Wenbo Zhao
Chang Zheng

doi 10.3389/fendo.2025.1629675

1,293 views

REVIEW

Published on 05 Jun 2025

Sodium-glucose transporter 2 inhibitors and cardiovascular-kidney-metabolic syndrome: a narrative review

Yuqing Wang
Yaqing Wang
Xiaojie He
Xiaodong Li

doi 10.3389/fendo.2025.1554637

2,817 views

ORIGINAL RESEARCH

Published on 30 Apr 2025

Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: a FIGARO-DKD subgroup analysis

Ping Li
Hongguang Zheng
Jianhua Ma
Weiping Lu
Ling Li
Fang Liu
Qing Su
Yuxiu Li
Yi Fang
7 more
Dalong Zhu

doi 10.3389/fendo.2025.1568438

3,533 views

ORIGINAL RESEARCH

Published on 16 Apr 2025

Baseline comorbidity of cardiovascular-kidney-metabolic syndrome increases the risk of adverse clinical outcomes in patients with chronic kidney disease

Jiali Meng
Wen Li
Wenjing Fu
Aihua Zhang

doi 10.3389/fendo.2025.1563164

2,742 views

ORIGINAL RESEARCH

Published on 10 Apr 2025

hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients

Fengjiao Han
Haiyang Guo
Hao Zhang
Yang Zheng

doi 10.3389/fendo.2025.1552219

5,183 views
2 citations

Share on

Frontiers in Endocrinology

Cardiovascular Endocrinology
Renal Endocrinology

Impact

24kTopic views
17kArticle views
5,573Article downloads

View impact

Articles

Associations between triglyceride glucose-body mass index and cardiovascular, renal, hepatic and bone biomarkers in patients with type 2 diabetes: A single-center, cross-sectional study

The impact of short-term comprehensive treatment on cardiovascular-kidney-metabolic syndrome and its components in patients with type 2 diabetes

Comparison of triglyceride-glucose index and triglyceride-glucose related indexes in predicting cardiovascular disease incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study

Osteoarthritis as a Clinical Marker of Cardiovascular-Kidney-Metabolic Multimorbidity: A Population-Based Cohort Study in China

Association Between Onset Age and Mortality Gradients in Advanced Cardio-Kidney-Metabolic Syndrome

Alcohol Consumption, High-Sensitivity C-Reactive Protein, and Estimated Glomerular Filtration Rate: Tripartite Predictors of 10-Year Cardiovascular Risk Progression in Patients with Type 2 Diabetes Mellitus After COVID-19

Risk Factors for Advance Stage Cardiovascular-Renal-Metabolic Syndrome in Patients with Early-Onset Type 2 Diabetes Mellitus

Cardiovascular-kidney-metabolic comorbidities in colorectal cancer survivors: a nationwide cohort study on the role of metabolic syndrome

Sodium-glucose transporter 2 inhibitors and cardiovascular-kidney-metabolic syndrome: a narrative review

Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: a FIGARO-DKD subgroup analysis

Baseline comorbidity of cardiovascular-kidney-metabolic syndrome increases the risk of adverse clinical outcomes in patients with chronic kidney disease

hs-CRP/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients

Frontiers in Endocrinology

Cardiovascular Endocrinology

Renal Endocrinology